CASREYO Trademark

Trademark Overview

On Monday, December 20, 2021, a trademark application was filed for CASREYO with the United States Patent and Trademark Office. The USPTO has given the CASREYO trademark a serial number of 97180806. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The CASREYO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
casreyo

General Information

Serial Number97180806
Word MarkCASREYO
Filing DateMonday, December 20, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, December 23, 2021NEW APPLICATION ENTERED
Monday, December 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, April 10, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, April 10, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, August 8, 2022ASSIGNED TO EXAMINER
Monday, August 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 30, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, May 1, 2023SOU EXTENSION 1 GRANTED
Monday, May 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 8, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 8, 2024SOU EXTENSION 3 FILED
Thursday, May 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 4 GRANTED
Friday, October 25, 2024SOU EXTENSION 4 FILED

Related Keywords

casreyo pharmaceutical treatment preparations cells primarily comprising beta thalassemia disease cell